| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |